Diclofenac: Potent NSAID for Effective Pain and Inflammation Relief
Diclofenac
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.54 | $49.00 (0%) | 🛒 Add to cart |
| 180 | $0.41 | $98.00 $73.00 (26%) | 🛒 Add to cart |
| 270 | $0.37 | $147.00 $99.00 (33%) | 🛒 Add to cart |
| 360 | $0.34
Best per pill | $196.00 $121.00 (38%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.37 | $67.00 (0%) | 🛒 Add to cart |
| 270 | $0.33 | $100.50 $88.00 (12%) | 🛒 Add to cart |
| 360 | $0.31
Best per pill | $134.00 $110.00 (18%) | 🛒 Add to cart |
Diclofenac is a widely prescribed nonsteroidal anti-inflammatory drug (NSAID) renowned for its potent analgesic, anti-inflammatory, and antipyretic properties. As a cornerstone in the management of acute and chronic pain conditions, it works by inhibiting cyclooxygenase (COX) enzymes, thereby reducing the production of prostaglandins, key mediators of pain and inflammation. Available in various formulations—including oral tablets, topical gels, and injectable solutions—diclofenac offers flexible treatment options tailored to specific clinical needs and patient profiles. Its efficacy and well-established safety profile make it a first-line therapeutic choice for healthcare providers across multiple specialties.
Features
- Active Ingredient: Diclofenac sodium or diclofenac potassium
- Drug Class: Nonsteroidal anti-inflammatory drug (NSAID)
- Available Formulations: Oral tablets (including extended-release), capsules, topical gel, solution, patches, ophthalmic solution, and injectable form
- Mechanism of Action: Reversible inhibition of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes
- Bioavailability: Approximately 50-60% for oral forms; variable for topical applications
- Half-life: 1-2 hours (oral), with sustained release forms extending duration
- Metabolism: Primarily hepatic via cytochrome P450 enzymes (CYP2C9)
- Excretion: Mainly renal (65-90%), with some biliary excretion
Benefits
- Provides rapid and effective relief from moderate to severe pain associated with inflammatory conditions
- Significantly reduces swelling, stiffness, and joint inflammation in arthritic disorders
- Offers multiple administration routes for tailored treatment approaches and improved patient compliance
- Demonstrates proven efficacy in managing acute migraine attacks and postoperative pain
- Helps restore mobility and improve quality of life in patients with chronic musculoskeletal conditions
- Available as both prescription and (in some regions) over-counter formulations for accessible pain management
Common use
Diclofenac is extensively used in clinical practice for managing various pain and inflammatory conditions. Its primary indications include osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, where it effectively reduces joint pain and improves mobility. In acute settings, it’s employed for postoperative pain management, dental pain, and musculoskeletal injuries such as sprains and strains. The topical formulation is particularly valuable for localized conditions like tendinitis and minor arthritis affecting peripheral joints. Additionally, diclofenac is used for managing acute gout attacks, dysmenorrhea, and migraine headaches. The ophthalmic solution is specifically indicated for postoperative inflammation following cataract surgery and for the treatment of seasonal allergic conjunctivitis.
Dosage and direction
Oral Tablets (Immediate Release): Adults typically take 50 mg three times daily or 75 mg twice daily for most conditions. The maximum recommended daily dose is 150 mg.
Extended-Release Tablets: Usually administered as 100 mg once daily for chronic conditions.
Topical Gel: Apply 4g of 1% gel to the affected area four times daily, with a maximum of 32g per day for all affected joints.
Ophthalmic Solution: Instill one drop into the affected eye(s) four times daily.
Dosage should be individualized based on the condition being treated, patient response, and risk factors. Oral formulations should be taken with food or milk to minimize gastrointestinal upset. For topical applications, apply to intact skin only and avoid contact with eyes and mucous membranes. Treatment duration should be the shortest possible consistent with therapeutic goals, particularly for chronic conditions.
Precautions
Patients with a history of gastrointestinal bleeding or ulceration require careful monitoring and concomitant gastroprotective therapy. Regular assessment of renal function is recommended, especially in elderly patients or those with pre-existing renal impairment, dehydration, or heart failure. Hepatic function should be monitored during long-term therapy due to potential hepatotoxicity. Caution is advised in patients with hypertension, as NSAIDs may elevate blood pressure and interfere with antihypertensive medications. Patients with asthma, especially those with aspirin-sensitive asthma, may experience exacerbations. Topical formulations may cause photosensitivity reactions, requiring sun protection measures. Use during pregnancy, particularly in the third trimester, should be avoided due to potential fetal cardiovascular complications.
Contraindications
Diclofenac is contraindicated in patients with known hypersensitivity to diclofenac, other NSAIDs, or any component of the formulation. It must not be used in patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Contraindications include active gastrointestinal bleeding or ulceration, severe heart failure, established renal disease, severe hepatic impairment, and during the third trimester of pregnancy. It should not be administered concurrently with other NSAIDs, including selective COX-2 inhibitors, due to increased risk of adverse effects. Recent coronary artery bypass graft (CABG) surgery represents an additional contraindication.
Possible side effect
Common (≥1%): Gastrointestinal disturbances including dyspepsia, nausea, abdominal pain, diarrhea; headache; dizziness; elevated liver enzymes; skin reactions at application site (topical formulations)
Less common (0.1-1%): Gastrointestinal ulceration or bleeding, hypertension, fluid retention, edema, tinnitus, pruritus, rash
Rare (<0.1%): Severe cutaneous adverse reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis), anaphylactic reactions, aseptic meningitis, blood dyscrasias, severe hepatotoxicity, renal papillary necrosis
Ophthalmic use: Burning sensation, itching, redness, blurred vision (typically transient)
Most adverse effects are dose-dependent and more likely with long-term use. Patients should be advised to report any unusual symptoms promptly, particularly signs of gastrointestinal bleeding, skin reactions, or visual disturbances.
Drug interaction
Diclofenac may interact significantly with several medication classes. Concurrent use with other NSAIDs or corticosteroids increases the risk of gastrointestinal ulceration and bleeding. It may reduce the effectiveness of antihypertensive agents, particularly ACE inhibitors, angiotensin II receptor blockers, and diuretics. Diclofencan increase lithium levels and methotrexate toxicity, requiring dosage adjustments and close monitoring. It may potentiate the effects of warfarin and other anticoagulants, increasing bleeding risk. Concomitant use with selective serotonin reuptake inhibitors (SSRIs) also elevates bleeding risk. Cyclosporine and tacrolimus nephrotoxicity may be enhanced. Aspirin may decrease diclofenac concentrations while increasing adverse effects.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Patients should not double the dose to make up for a missed one. For topical formulations, apply the missed dose when remembered, then continue with the next application at the regular time. Consistency in administration is important for maintaining therapeutic effects, particularly for chronic conditions. Healthcare providers should provide specific guidance based on the formulation and indication.
Overdose
Symptoms of overdose may include nausea, vomiting, epigastric pain, gastrointestinal bleeding, drowsiness, dizziness, tinnitus, and headache. More severe cases may involve acute renal failure, liver damage, respiratory depression, coma, or convulsions. Management is primarily supportive and symptomatic. Gastric lavage or activated charcoal may be considered if presentation is early after ingestion. Forced diuresis, alkalinization of urine, hemodialysis, or hemoperfusion are not effective due to high protein binding. Specific treatments may include intravenous fluids for hypotension, anticonvulsants for seizures, and blood transfusion if significant bleeding occurs. Patients should seek immediate medical attention for suspected overdose.
Storage
Store at room temperature (15-30°C or 59-86°F) in the original container, protected from light and moisture. Keep oral formulations tightly closed and away from excessive heat. Topical gels and solutions should not be frozen. All medications should be kept out of reach of children and pets. Do not transfer medications to other containers, as this may affect stability and lead to dosing errors. Check expiration dates regularly and properly dispose of expired or unused medication according to local regulations. Do not flush medications down the toilet or drain unless specifically instructed to do so.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Individual patient needs may vary, and healthcare professionals should make treatment decisions based on their clinical judgment and current prescribing information. The prescribing physician should be consulted for specific dosage recommendations and treatment duration. Patients should not initiate or modify therapy without professional medical supervision. While every effort has been made to ensure accuracy, medical knowledge evolves, and newer information may supersede these recommendations.
Reviews
Clinical studies consistently demonstrate diclofenac’s efficacy in pain management, with meta-analyses showing superior pain relief compared to placebo and comparable effectiveness to other NSAIDs. Rheumatology guidelines frequently recommend diclofenac as a first-line option for inflammatory arthritis based on extensive clinical trial data. Patient-reported outcomes indicate significant improvements in pain scores and quality of life measures. The topical formulation has received positive evaluations for localized pain relief with reduced systemic exposure. However, recent cardiovascular safety concerns have led to more cautious prescribing in high-risk populations. Overall, diclofenac remains a valuable therapeutic option when used appropriately with consideration of individual risk factors.